We demonstrate that TSA is a promising NQO1 specific target agent, which induces apoptotic cell death of NSCLC cells via a unique NQO1-initiated and ROS-mediated activation of a p53-independent but caspase-dependent mitochondrial apoptotic pathway. The gene discussed is TP53; the disease is non-small cell lung carcinoma.